BR112019010115A8 - Método de proporcionar benefícios de higiene bucal - Google Patents

Método de proporcionar benefícios de higiene bucal

Info

Publication number
BR112019010115A8
BR112019010115A8 BR112019010115A BR112019010115A BR112019010115A8 BR 112019010115 A8 BR112019010115 A8 BR 112019010115A8 BR 112019010115 A BR112019010115 A BR 112019010115A BR 112019010115 A BR112019010115 A BR 112019010115A BR 112019010115 A8 BR112019010115 A8 BR 112019010115A8
Authority
BR
Brazil
Prior art keywords
oral hygiene
providing oral
hygiene benefits
oral
providing
Prior art date
Application number
BR112019010115A
Other languages
English (en)
Other versions
BR112019010115A2 (pt
Inventor
R Geonnotti Anthony
L Golas Patricia
Wittorff Helle
Ziegler Bruun Heidi
Schackinger Boesen Dorthe
Original Assignee
Fertin Pharma As
Johnson & Johnson Consumer Inc
Currahee Holding Company Inc
Chenango Zero Llc
Chenango Two Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/356,175 external-priority patent/US10543205B2/en
Priority claimed from PCT/DK2016/050377 external-priority patent/WO2018091048A1/en
Application filed by Fertin Pharma As, Johnson & Johnson Consumer Inc, Currahee Holding Company Inc, Chenango Zero Llc, Chenango Two Llc filed Critical Fertin Pharma As
Publication of BR112019010115A2 publication Critical patent/BR112019010115A2/pt
Publication of BR112019010115A8 publication Critical patent/BR112019010115A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Confectionery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A presente invenção revela métodos para fornecer, pelo menos, um benefício de cuidados orais através da introdução de um comprimido para a cavidade oral para gerar um fluido e forçar pelo menos uma porção de fluido gerado em torno da cavidade oral, por exemplo, por sibilante, lavagem, lavagem, etc, para proporcionar um benefício de assistência oral.
BR112019010115A 2016-11-18 2017-10-13 Método de proporcionar benefícios de higiene bucal BR112019010115A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/356,175 US10543205B2 (en) 2016-11-18 2016-11-18 Oral delivery vehicle containing nicotine
PCT/DK2016/050377 WO2018091048A1 (en) 2016-11-18 2016-11-18 Oral delivery vehicle
PCT/US2017/056554 WO2018093501A1 (en) 2016-11-18 2017-10-13 Method of providing oral care benefits

Publications (2)

Publication Number Publication Date
BR112019010115A2 BR112019010115A2 (pt) 2019-08-20
BR112019010115A8 true BR112019010115A8 (pt) 2022-07-26

Family

ID=60083055

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112019008138A BR112019008138A2 (pt) 2016-11-18 2017-10-13 comprimido que compreende agente aglutinante e eritritol separados
BR112019010115A BR112019010115A8 (pt) 2016-11-18 2017-10-13 Método de proporcionar benefícios de higiene bucal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112019008138A BR112019008138A2 (pt) 2016-11-18 2017-10-13 comprimido que compreende agente aglutinante e eritritol separados

Country Status (14)

Country Link
EP (2) EP3541360A1 (pt)
JP (2) JP6840849B2 (pt)
KR (1) KR102582802B1 (pt)
CN (2) CN109952092B (pt)
AU (4) AU2017360378A1 (pt)
BR (2) BR112019008138A2 (pt)
CA (2) CA3044382A1 (pt)
DK (1) DK3541359T3 (pt)
ES (1) ES2860802T3 (pt)
MA (1) MA46822A (pt)
MX (2) MX2019005928A (pt)
PL (1) PL3541359T3 (pt)
RU (1) RU2736072C1 (pt)
WO (2) WO2018093501A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US20190350858A1 (en) * 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11058641B2 (en) * 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11096895B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096896B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
AU2019268497B2 (en) * 2018-05-17 2022-01-06 Fertin Pharma A/S A tableted chewing gum suitable for active pharmaceutical ingredients
US11135157B2 (en) * 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
KR102345862B1 (ko) * 2021-03-18 2022-01-03 김현진 팝핑 성분을 포함하는 고체 구강청결용 조성물

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
EP0922464B1 (en) * 1996-07-12 2005-03-30 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
AU1031500A (en) 1998-11-03 2000-05-22 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
CA2440361A1 (en) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
JP2003125706A (ja) * 2001-10-23 2003-05-07 Lion Corp 口中清涼製剤
US20040101494A1 (en) * 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
AU2005282770A1 (en) * 2004-09-02 2006-03-16 The Procter & Gamble Company Oral care composition comprising essential oils
US8435542B2 (en) 2005-03-03 2013-05-07 Takasago International Corp. (Usa) Synergistic salivation agents
JP2006335686A (ja) * 2005-06-02 2006-12-14 Hamari Chemicals Ltd 直打用エリスリトール・ソルビトール混合顆粒の製造方法
CN1709229A (zh) * 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CN100446759C (zh) * 2006-10-16 2008-12-31 北京科信必成医药科技发展有限公司 一种天麻素口腔崩解片及其制备方法
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
WO2009007768A1 (en) * 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
RU2479587C2 (ru) * 2007-07-27 2013-04-20 Карджилл, Инкорпорейтед Микронизация полиолов
EP2334202B1 (en) * 2008-09-04 2012-02-01 Cargill, Incorporated Tabletting of ervthritol
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
WO2013125350A1 (ja) * 2012-02-23 2013-08-29 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
US10357054B2 (en) * 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
EP3131639B1 (en) * 2014-04-17 2018-09-26 Unilever PLC Solid oral care compositions comprising calcium carbonate and polyethylene oxide
JP6718866B2 (ja) * 2014-10-16 2020-07-08 カーギル インコーポレイテッド 直接圧縮性のエリスリトールの調製方法及びその使用
BR112017009601B8 (pt) 2014-11-11 2022-07-26 Johnson & Johnson Consumer Inc Derivados de aminoácidos e composição que os compreende
CN104546807B (zh) * 2015-01-21 2020-09-01 齐鲁制药有限公司 奥氮平口腔速溶膜剂

Also Published As

Publication number Publication date
BR112019008138A2 (pt) 2019-07-02
KR102582802B1 (ko) 2023-10-06
MX2019005828A (es) 2019-07-08
PL3541359T3 (pl) 2021-05-31
WO2018093501A1 (en) 2018-05-24
CA3044382A1 (en) 2018-05-24
CN109952092B (zh) 2022-08-23
JP2019535732A (ja) 2019-12-12
AU2017360584A1 (en) 2019-05-02
BR112019010115A2 (pt) 2019-08-20
CN110087634A (zh) 2019-08-02
AU2017360378A1 (en) 2019-06-06
ES2860802T3 (es) 2021-10-05
AU2021200826B2 (en) 2022-02-17
CA3040830A1 (en) 2018-05-24
JP7297666B2 (ja) 2023-06-26
RU2736072C1 (ru) 2020-11-11
EP3541359B1 (en) 2021-01-27
AU2017360584B2 (en) 2020-12-17
CN109952092A (zh) 2019-06-28
RU2019118433A (ru) 2020-12-18
AU2021200826A1 (en) 2021-03-04
MA46822A (fr) 2019-09-25
AU2023214357A1 (en) 2023-08-31
CA3040830C (en) 2021-06-15
KR20190086512A (ko) 2019-07-22
JP2019535729A (ja) 2019-12-12
JP6840849B2 (ja) 2021-03-10
EP3541359A1 (en) 2019-09-25
RU2019118433A3 (pt) 2020-12-18
DK3541359T3 (da) 2021-02-22
EP3541360A1 (en) 2019-09-25
WO2018091050A1 (en) 2018-05-24
MX2019005928A (es) 2019-11-12

Similar Documents

Publication Publication Date Title
BR112019010115A8 (pt) Método de proporcionar benefícios de higiene bucal
BR112017009806A2 (pt) sistema e método para gerar informações de nível de estresse e de nível de resiliência de estresse para um indivíduo
CL2016001979A1 (es) Métodos de tratamiento de enfermedad de alzheimer.
CR20160485A (es) Compuesto de ciclopropanamina y sus usos
CL2018003489A1 (es) Composición y método para reducir neutropenia
CO2017013065A2 (es) Moduladores de diaciglicerol aciltransferasa 2 (dgat2)
CL2015002122A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
MX2017000254A (es) Sistema para la administracion de una composicion de higiene bucal.
IL261856B (en) Use of masitinib to treat a subpopulation of amyotrophic lateral sclerosis patients
BR112017022089A2 (pt) uso de uma composição, e, método para branqueamento de dentes
CL2017002031A1 (es) Formulación en polvo nasal para el tratamiento de hipoglicemia
MX2018016362A (es) Formulaciones de anticuerpo anti-cd19.
CL2017001120S1 (es) Posicionador dental (divisional solicitud 18-2016)
BR112019020338A8 (pt) Composição para produção de tagatose, e, método de produção de tagatose
BR112018074491A2 (pt) método de produção de ácido a-hidromucônico e micro-organismo pertencente ao gênero serratia capaz de produzir ácido a-hidromucônico
BR112018006870A2 (pt) nanopartículas terapêuticas que compreendem um agente terapêutico e métodos para a produção e o uso das mesmas
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
CY1122374T1 (el) Βιοτινη για την θεραπευτικη αντιμετωπιση απομυελινωτικων νευροπαθειων
BR112017012938A2 (pt) uso por via oral de uma composição e método para aprimorar a aparência da celulite
TR201906876T4 (tr) Amniyotik sıvının tanımlanması için tanısal kompozisyon.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
EP3353611A4 (en) SOLUTION-RELATED OUTPUT TIMES FOR MODELS OF DYNAMIC SYSTEMS
RU2014154366A (ru) Применение пробиотического штамма микроорганизма enterococcus faecium l3 для лечения нейродегенеративных заболеваний
BR112015027707A2 (pt) Método de preparação de derivados de 3,5-bis(fluoroalquil)pirazole e compostos intermediários envolvidos nesse método
EA201891794A1 (ru) Композиция для ухода за полостью рта

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: FERTIN PHARMA A/S (DK) ; CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: FERTIN PHARMA A/S (DK) ; CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: FERTIN PHARMA A/S (DK) ; CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: FERTIN PHARMA A/S (DK) ; JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) ; FERTIN PHARMA A/S (DK)

B25D Requested change of name of applicant approved

Owner name: FERTIN PHARMA A/S (DK) ; JOHNSON AND JOHNSON CONSUMER INC. (US)